Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’
Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’ Pharmaceutical Technology
Regulatory Approvals
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva Patient Care Online
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth Pharmacy Times
Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test
Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test insights.citeline.com
FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from…